El En SpA
LSE:0RH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
El En SpA
LSE:0RH2
|
IT |
|
E
|
Envoy Medical Inc
NASDAQ:COCH
|
US |
Wall St Price Targets
0RH2 Price Targets Summary
El En SpA
According to Wall Street analysts, the average 1-year price target for 0RH2 is 17.98 EUR with a low forecast of 16.16 EUR and a high forecast of 19.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RH2's stock price target?
Price Target
17.98
EUR
According to Wall Street analysts, the average 1-year price target for 0RH2 is 17.98 EUR with a low forecast of 16.16 EUR and a high forecast of 19.95 EUR.
What is the Revenue forecast for El En SpA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for El En SpA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for El En SpA?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for El En SpA?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 27%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for El En SpA?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
